The Algerian Ministry of Health launched a national vaccination campaign against seasonal flu on October 27, 2026. The campaign aims to protect vulnerable populations, including people over 65, those with chronic illnesses, and pregnant women. According to Dr. Fawzi Derrar, director-general of the Pasteur Institute of Algeria, it takes about three weeks for the body to develop sufficient immunity after vaccination.
The vaccination campaign is crucial this year, as delaying vaccination until January could compromise its effectiveness. Dr. Derrar warned that waiting until January would coincide with the peak epidemic period, reducing the vaccine's impact. The Ministry of Health emphasizes the importance of early vaccination, particularly for those most exposed to flu complications.
The campaign targets several high-risk groups, including people over 65, those with chronic illnesses, and children with these conditions. Additionally, individuals with severe obesity, pregnant women, pilgrims, and healthcare professionals are also eligible for vaccination. By vaccinating these groups, the Ministry of Health aims to reduce the risk of severe complications and prevent overcrowding in healthcare facilities during the winter season.
To ensure the campaign's success, over two million doses of vaccine have been secured for the 2026-2027 season. According to Djamel Fourar, director-general of prevention and health promotion, 1.6 million doses have already been distributed to healthcare facilities and hospitals. The vaccine is produced locally as part of a partnership between the pharmaceutical group Saidal and Abbott laboratories.
The Algerian government stresses the importance of time in the vaccination campaign. The goal is to provide protection to targeted individuals before the peak flu season. Cooperation from the public and adherence to the recommended vaccination period are crucial in limiting severe flu cases and preserving healthcare capacities.
The vaccination campaign is part of Algeria's national prevention strategy to combat seasonal flu. By promoting vaccination, the government aims to reduce the spread of the virus and protect vulnerable populations. The campaign's success will depend on public participation and the timely administration of vaccines.
The Ministry of Health encourages eligible individuals to get vaccinated as soon as possible. With the right timing and public cooperation, the campaign can effectively reduce the impact of seasonal flu in Algeria. The government remains committed to ensuring the well-being and health of its citizens through proactive measures like this vaccination campaign.
Key points
- The Algerian government has launched a national vaccination campaign against seasonal flu, targeting vulnerable populations.
- The campaign aims to reduce the risk of severe complications and prevent overcrowding in healthcare facilities during the winter season.
- Over two million doses of vaccine have been secured for the 2026-2027 season, with 1.6 million doses already distributed to healthcare facilities and hospitals.
